AAPL 186.61 +0.12 (+0.06%)MSFT 126.9 +0.03 (+0.02%)FB 184.76 +0.03 (+0.02%)ZNGA 6.17 0 (+0.08%)NVDA 155.05 -0.2 (-0.13%)WBA 52.73 +0.06 (+0.11%)GOOG 1148.79 -1.09 (-0.09%)PIH 5.7 -0.12 (-2.06%)
AAPL 186.61 +0.12 (+0.06%)MSFT 126.9 +0.03 (+0.02%)FB 184.76 +0.03 (+0.02%)ZNGA 6.17 0 (+0.08%)NVDA 155.05 -0.2 (-0.13%)WBA 52.73 +0.06 (+0.11%)GOOG 1148.79 -1.09 (-0.09%)PIH 5.7 -0.12 (-2.06%)

Financial Summary GTXI Quote GTx Inc.

GTx Inc. Quote

GTx Inc. (GTXI)

1.04 0 Healthcare
Stock Performance rating :
Recommendation :
Strong Sell
Score :
D+
Symbol GTXI
Price 1.04
Beta 2.57
Vol Avg 119.86 K
Mkt cap 28.38 M
Shares 15
Last Div Not Available
Div Yield 0.00%
DCF Unlevered 0.00
DCF Levered 0.00
ROE -1900.00% Strong Sell
ROA -118.75% Strong Sell
Operating Margin -Infinity% Strong Sell
Debt/Equity 1500.00% Strong Buy
P/E -0.82
P/B 7.80 Strong Buy
All | Income Statement | Balance Sheet | Cash Flow | Retained Earnings | PPE Schedule | Intangible and Goodwill Schedule
Income Statement
Year 20142015201620172018
Revenue 0 0 0 0 0
COGS 0 0 0 0 0
GrossProfit 0 0 0 0 0
Depreciation (included in COGS) 0 0 0 0 0
StockBasedCompe (included in COGS) 4 5 3 3 3
ResearchAndDeve 32 21 14 17 21
SalesGeneralAnd 11 9 8 9 9
OperatingIncome -44 -30 -22 -26 -31
InterestExpense 0 0 0 0 0
OtherIncome 1 -9 3 8 0
IncomeBeforeTax -42 -39 -19 -18 -30
ProvisionForInc 0 0 0 0 0
NetIncome -42 -39 -19 -18 -30
Balance Sheet
Year 20142015201620172018
CashAndCashEqui 15 18 14 9 16
ShortTermInvest 0 31 15 13 28
Cash 15 49 29 0 0
AccountReceivab 0 0 0 0 0
Inventories 0 0 0 0 0
DeferredIncomeT 0 0 0 0 0
OtherCurrentAss 0 0 0 0 0
TotalCurrentAss 15 50 32 24 46
PPE 4 4 3 3 3
AccumulatedDepr -4 -4 -3 -3 -3
NetPPE 0 0 0 0 0
EquityAndOtherI 0 0 0 0 0
Goodwill 0 0 0 0 0
IntangibleAsset 0 0 0 0 0
OtherLTAssets 0 0 0 0 0
TotalNonCurrent 0 0 0 0 0
TotalAssets 16 51 32 25 46
ShortTermDebt 0 0 0 0 0
AccountsPayable 1 1 0 0 0
TaxesPayable 0 0 0 0 0
AccruedLiabilit 4 2 2 0 0
DeferredRevenue 0 0 0 0 0
OtherCurrentLia 0 31 27 0 0
TotalCurrentLia 5 33 30 5 8
Debt 0 0 0 0 0
DeferredTaxesLi 0 0 0 0 0
DeferredRevenue 0 0 0 0 0
OtherLTLiabilit 0 0 0 0 0
TotalNonCurrent 0 0 0 0 0
TotalLiabilitie 5 33 30 5 8
CommonStock 0 0 0 0 0
AdditionalPaidI 466 512 515 551 600
RetainedEarning -455 -495 -513 -531 -562
AccumulatedOthe 0 0 0 0 0
TotalStockholde 11 18 2 20 38
TotalLiabilitie 16 51 32 25 46
Cash Flow Statement
Year 20142015201620172018
NetIncome -42 -39 -19 -18 -30
Depreciation 0 0 0 0 0
DeferredIncomeT 0 0 0 0 0
StockBasedCompe 4 5 3 3 3
AccountsReceiva 0 0 0 0 0
InventoryCS 0 0 0 0 0
AccountsPayable -1 0 0 1 1
OtherWorkingCap 0 0 0 0 0
OtherNonCashIte -1 9 -3 -8 0
NetCashProvided -44 -29 -20 -21 -23
InvestmentsInPP 0 0 0 0 0
AcquisitionsNet 0 0 0 0 0
PurchasesOfInve -1 -42 -55 -35 -39
SalesMaturities 9 11 71 38 24
PurchasesOfInta 0 0 0 0 0
OtherInvestingA 0 0 0 0 0
NetCashUsedForI 9 -31 16 2 -15
DebtIssued 0 0 0 0 0
DebtRepayment 0 0 0 0 0
CommonStockIssu 0 64 0 14 46
CommonStockRepu 0 0 0 0 0
DividendPaid 0 0 0 0 0
OtherFinancingA 1 -1 0 0 0
NetCashProvided 1 63 0 13 45
NetChangeInCash -34 3 -4 -5 7
CashAtBeginning 48 15 18 14 9
CashAtEndOfPeri 15 18 14 9 16
Retained Earnings
Year 20142015201620172018
RetainedEarning ----455-495
NetIncome ---42-39-19
StockDividend --4977937
DividendPaid -----
RetainedEarning ---455-495-513
Property Plant and Equipment Schedule
Year 20142015201620172018
NetPPE -----
DeprAnnual 0--4-1
CapitalExpendit 00000
NetPPE -----
Intangible and Goodwill Schedule
Year 20142015201620172018
intAndGW 0----
Amortization 0-4--1
NewPurchases 0--4-1
intAndGW -----
Company Profile

CEO

Marc S. Hanover

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ Capital Market

Description

GTx Inc is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of small molecules for treatment of cancer, including treatments for breast and prostate cancer and other medical conditions.